HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Kahlert Selected Research

Stroke (Strokes)

8/2000Requirement of glycolytic and mitochondrial energy supply for loading of Ca(2+) stores and InsP(3)-mediated Ca(2+) signaling in rat hippocampus astrocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Kahlert Research Topics

Disease

17Breast Neoplasms (Breast Cancer)
11/2015 - 01/2000
7Neoplasms (Cancer)
04/2006 - 03/2000
2Chills
11/2005 - 07/2005
2Fever (Fevers)
11/2005 - 07/2005
1Inflammation (Inflammations)
02/2018
1Necrosis
02/2018
1Inflammatory Breast Neoplasms
08/2012
1Brain Neoplasms (Brain Tumor)
04/2006
1Neoplasm Metastasis (Metastasis)
04/2006
1Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
11/2005
1Ischemic Stroke
01/2004
1Ischemia
01/2004
1Stomach Neoplasms (Stomach Cancer)
08/2001
1Hyperglycemia
01/2001
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2001
1Cardiotoxicity
09/2000
1Stroke (Strokes)
08/2000
1Brain Hypoxia (Cerebral Hypoxia)
08/2000
1Hypoglycemia (Reactive Hypoglycemia)
08/2000
1Renal Cell Carcinoma (Grawitz Tumor)
03/2000
1Carcinoma (Carcinomatosis)
03/2000
1Glioblastoma (Glioblastoma Multiforme)
03/2000

Drug/Important Bio-Agent (IBA)

6Trastuzumab (Herceptin)FDA Link
04/2006 - 09/2000
4Epirubicin (Ellence)FDA LinkGeneric
12/2004 - 01/2000
3AnthracyclinesIBA
08/2012 - 12/2004
3GemcitabineFDA Link
05/2006 - 06/2001
3Proteins (Proteins, Gene)FDA Link
04/2006 - 09/2000
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2004 - 09/2000
3Adenosine Triphosphate (ATP)IBA
01/2004 - 08/2000
2taxaneIBA
08/2012 - 05/2006
2Cisplatin (Platino)FDA LinkGeneric
05/2006 - 12/2005
2Plasminogen Activator Inhibitor 1IBA
04/2006 - 08/2001
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
04/2006 - 08/2001
2Tissue ExtractsIBA
04/2006 - 08/2001
2EnzymesIBA
11/2005 - 07/2005
2AntibodiesIBA
07/2005 - 08/2001
2Glucose (Dextrose)FDA LinkGeneric
01/2004 - 01/2001
2Methotrexate (Mexate)FDA LinkGeneric
05/2001 - 09/2000
2Fluorouracil (Carac)FDA LinkGeneric
05/2001 - 09/2000
1LipopolysaccharidesIBA
02/2018
1KynurenineIBA
02/2018
1deoxynivalenolIBA
02/2018
1Tryptophan (L-Tryptophan)FDA Link
02/2018
1ParaffinIBA
11/2008
1Estrogen ReceptorsIBA
11/2008
1Progesterone Receptors (Progesterone Receptor)IBA
11/2008
1Plasminogen Activators (Plasminogen Activator)IBA
04/2006
1SurvivinIBA
04/2006
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2006
1Bispecific AntibodiesIBA
07/2005
1ErbB-2 ReceptorIBA
06/2005
1Monoclonal AntibodiesIBA
06/2005
1Oxygen (Dioxygen)IBA
01/2004
1Plasminogen InactivatorsIBA
08/2001
1Peptide Hydrolases (Proteases)FDA Link
08/2001
1Complementary DNA (cDNA)IBA
08/2001
1Vinorelbine (Navelbine)FDA LinkGeneric
06/2001
1Carboplatin (JM8)FDA LinkGeneric
06/2001
1Drug CombinationsIBA
06/2001
1Pharmaceutical PreparationsIBA
06/2001
1Paclitaxel (Taxol)FDA LinkGeneric
06/2001
1Proteoglycans (Proteoglycan)IBA
01/2001
1Heparitin Sulfate (Heparan Sulfate)IBA
01/2001
1AgrinIBA
01/2001
1Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
01/2001
1N 30IBA
03/2000

Therapy/Procedure

8Therapeutics
06/2005 - 03/2000
6Drug Therapy (Chemotherapy)
08/2012 - 01/2000
2Neoadjuvant Therapy
08/2012 - 04/2004
2Immunotherapy
11/2005 - 07/2005
1Segmental Mastectomy (Lumpectomy)
11/2015
1Adjuvant Radiotherapy
11/2015
1Combined Modality Therapy
11/2005
1Stem Cell Transplantation
07/2005
1Palliative Care (Palliative Therapy)
06/2004
1Cesarean Section (Caesarean Section)
06/2004